Eosinophilic granulomatosis with polyangiitis (EGPA) should be considered in people with uncontrolled severe asthma and high blood levels of…
Articles by Andrea Lobo, PhD
Most children with granulomatosis with polyangiitis (GPA) have respiratory manifestations including cough and shortness of breath at diagnosis, and…
People with ANCA-associated vasculitis (AAV) have a higher frequency of thyroid diseases, that is, those that affect the hormone-production…
Fasenra (benralizumab) has been granted approval in the European Union as an add-on treatment for adults with relapsing or…
Alivexis’ experimental oral therapy MOD06051, designed to suppress an underlying mechanism of ANCA-associated vasculitis (AAV), eased blood vessel…
People with ANCA-associated vasculitis (AAV) have a higher risk of cardiovascular diseases and related mortality than people without the…
A Phase 1 clinical trial evaluating the safety and preliminary efficacy of Adicet Bio’s CAR T-cell therapy ADI-001 in…
Patterns of lung damage on CT scans may help predict disease outcomes in people with ANCA-associated vasculitis (AAV) and…
A European Medicines Agency (EMA) committee has issued a positive opinion recommending the approval of Fasenra (benralizumab) as an…
Rituximab may be associated with a higher risk of serious adverse events, particularly infections, in people with granulomatosis with…